Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV‐exposed infants in a randomized controlled trial, Botswana

INTRODUCTION: Despite declining risk of vertical HIV transmission, prophylactic cotrimoxazole (CTX) remains widely used to reduce morbidity and mortality in the event of HIV infection among exposed infants, with an inherent risk of conferring commensal antimicrobial resistance. Using data from a ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Powis, Kathleen M, Souda, Sajini, Lockman, Shahin, Ajibola, Gbolahan, Bennett, Kara, Leidner, Jean, Hughes, Michael D, Moyo, Sikhulile, van Widenfelt, Erik, Jibril, Haruna B, Makhema, Joseph, Essex, Max, Shapiro, Roger L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810322/
https://www.ncbi.nlm.nih.gov/pubmed/29119726
http://dx.doi.org/10.1002/jia2.25021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810322/
https://www.ncbi.nlm.nih.gov/pubmed/29119726
http://dx.doi.org/10.1002/jia2.25021

Ejemplares similares